• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IS 与肾脏疾病及其并发症关系的研究进展。

Research progress on the relationship between IS and kidney disease and its complications.

机构信息

Department of Nephrology, Affiliated Hospital of Hebei University, No. 212 Yuhuadonglu, Baoding, 071000, People's Republic of China.

College of Clinical Medicine, Hebei University, No. 342 Yuhua Road, Baoding, 071000, People's Republic of China.

出版信息

Int Urol Nephrol. 2022 Nov;54(11):2881-2890. doi: 10.1007/s11255-022-03209-1. Epub 2022 Apr 29.

DOI:10.1007/s11255-022-03209-1
PMID:35488145
Abstract

Indoxyl sulphate (IS) a representative uraemic toxin in the blood of patients with chronic kidney disease (CKD). Its accumulation may be closely related to CKD and the increasing morbidity and mortality of the disease's related complications. Timely and effective detection of the IS level and efficient clearance of IS may effectively prevent the progression of CKD and its related complications. Therefore, this article summarizes the research progress of IS related, including IS in CKD and its associated complications including chronic kidney disease, chronic kidney disease with cardiovascular disease, renal anemia, bone mineral metabolic disease and neuropsychiatric disorders, looking for IS accurate rapid detection methods, and explore the efficient treatment to reduce blood levels of indole phenol sulphate.

摘要

硫酸吲哚酚(IS)是慢性肾脏病(CKD)患者血液中的一种代表性尿毒症毒素。其蓄积可能与 CKD 及其相关并发症的发病率和死亡率增加密切相关。及时有效地检测 IS 水平并有效清除 IS 可能有效预防 CKD 及其相关并发症的进展。因此,本文总结了 IS 相关的研究进展,包括 IS 在 CKD 及其相关并发症中的作用,包括慢性肾脏病、合并心血管疾病的慢性肾脏病、肾性贫血、骨矿物质代谢疾病和神经精神障碍,寻找 IS 的准确快速检测方法,并探讨有效的治疗方法以降低血液中吲哚酚硫酸盐的水平。

相似文献

1
Research progress on the relationship between IS and kidney disease and its complications.IS 与肾脏疾病及其并发症关系的研究进展。
Int Urol Nephrol. 2022 Nov;54(11):2881-2890. doi: 10.1007/s11255-022-03209-1. Epub 2022 Apr 29.
2
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?慢性肾脏病与神经病变:尿毒症毒素是缺失的一环吗?
Nephrol Dial Transplant. 2021 Dec 28;37(Suppl 2):ii33-ii44. doi: 10.1093/ndt/gfab223.
3
Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病中降低蛋白结合型尿毒症毒素的策略:系统评价和荟萃分析。
J Nephrol. 2021 Dec;34(6):1805-1817. doi: 10.1007/s40620-020-00955-2. Epub 2021 Jan 23.
4
Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease.饮食质量与蛋白质结合型尿毒症毒素:慢性肾脏病新危险因素及微生物群作用的研究
J Ren Nutr. 2022 Sep;32(5):542-551. doi: 10.1053/j.jrn.2021.10.003. Epub 2021 Nov 12.
5
Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.慢性肾脏病(CKD)患者体内的蛋白结合型尿毒症毒素(PBUTs):产生途径、面临的挑战及肾脏 PBUTs 清除的最新进展。
NanoImpact. 2021 Jan;21:100299. doi: 10.1016/j.impact.2021.100299. Epub 2021 Jan 28.
6
Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis?血液透析患者肠道微生物群产生的尿毒症毒素血浆水平与贫血之间是否存在关联?
Int Urol Nephrol. 2022 Jun;54(6):1271-1277. doi: 10.1007/s11255-021-03001-7. Epub 2021 Sep 24.
7
Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence.急性肾损伤和慢性肾脏病中的尿毒症毒素和蛋白结合治疗药物:最新证据。
Toxins (Basel). 2021 Dec 23;14(1):8. doi: 10.3390/toxins14010008.
8
Does Mediterranean Adequacy Index Correlate with Cardiovascular Events in Patients with Advanced Chronic Kidney Disease? An Exploratory Study.地中海饮食充足度指数与晚期慢性肾脏病患者心血管事件的相关性:一项探索性研究。
Nutrients. 2022 Apr 19;14(9):1687. doi: 10.3390/nu14091687.
9
[Research progress of the uremic toxin indoxyl sulfate in cardiovascular complication of end-stage renal diseases].[尿毒症毒素硫酸吲哚酚在终末期肾病心血管并发症中的研究进展]
Sheng Li Xue Bao. 2018 Dec 25;70(6):657-662.
10
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.硫酸吲哚酚——一种将慢性肾病患者的止血系统紊乱与心血管疾病患病率联系起来的尿毒症毒素。
BMC Nephrol. 2017 Jan 25;18(1):35. doi: 10.1186/s12882-017-0457-1.

引用本文的文献

1
Serum Indoxyl Sulfate as a Potential Biomarker of Peripheral Arterial Stiffness in Patients with Non-Dialysis Chronic Kidney Disease Stages 3 to 5.血清硫酸吲哚酚作为非透析慢性肾脏病3至5期患者外周动脉僵硬度的潜在生物标志物
Toxins (Basel). 2025 Jun 5;17(6):283. doi: 10.3390/toxins17060283.
2
Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3-5 not receiving dialysis.未接受透析的慢性肾脏病 3-5 期患者继发甲状旁腺功能亢进的代谢组学特征。
Front Endocrinol (Lausanne). 2024 Jul 4;15:1406690. doi: 10.3389/fendo.2024.1406690. eCollection 2024.
3
Plasma indole-3-aldehyde as a novel biomarker of acute kidney injury after cardiac surgery: a reanalysis using prospective metabolomic data.

本文引用的文献

1
Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017.2017 年全球疾病负担研究:1990 年至 2017 年 2 型糖尿病导致的慢性肾脏病流行趋势变化。
J Diabetes Investig. 2021 Mar;12(3):346-356. doi: 10.1111/jdi.13355. Epub 2020 Aug 17.
2
Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF-κB signaling pathway.硫酸吲哚酚诱导血管平滑肌细胞钙化通过 PI3K/Akt/NF-κB 信号通路。
Microsc Res Tech. 2019 Dec;82(12):2000-2006. doi: 10.1002/jemt.23369. Epub 2019 Aug 25.
3
Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
血浆吲哚-3-乙醛作为心脏手术后急性肾损伤的新型生物标志物:使用前瞻性代谢组学数据进行的再分析。
BMC Anesthesiol. 2023 Nov 7;23(1):364. doi: 10.1186/s12871-023-02330-7.
硫酸吲哚酚与慢性肾脏病儿童的心血管表型有关。
Pediatr Nephrol. 2019 Dec;34(12):2571-2582. doi: 10.1007/s00467-019-04331-6. Epub 2019 Aug 19.
4
Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey.中国农村居民慢性肾脏病和糖尿病肾病的患病率及相关危险因素:一项横断面调查。
Sci Rep. 2019 Jul 18;9(1):10408. doi: 10.1038/s41598-019-46857-7.
5
Indoxyl sulfate-induced TNF-α is regulated by crosstalk between the aryl hydrocarbon receptor, NF-κB, and SOCS2 in human macrophages.靛玉红硫酸盐诱导的 TNF-α 通过人巨噬细胞中芳香烃受体、NF-κB 和 SOCS2 的串扰进行调节。
FASEB J. 2019 Oct;33(10):10844-10858. doi: 10.1096/fj.201900730R. Epub 2019 Jul 5.
6
Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease.建立并验证一种 UHPLC-MS/MS 法用于检测人血清中肠道来源尿毒症毒素谱:在肾脏病患者中的应用。
J Pharm Biomed Anal. 2019 Sep 10;174:618-624. doi: 10.1016/j.jpba.2019.06.033. Epub 2019 Jun 24.
7
Klotho restrain RIG-1/NF-κB signaling activation and monocyte inflammatory factor release under uremic condition.Klotho 可抑制尿毒症条件下 RIG-1/NF-κB 信号激活和单核细胞炎症因子释放。
Life Sci. 2019 Aug 15;231:116570. doi: 10.1016/j.lfs.2019.116570. Epub 2019 Jun 14.
8
Performance evaluation of an Indoxyl Sulfate Assay Kit "NIPRO".NIPRO 吲哚硫酸酯试剂盒的性能评估。
Clin Chem Lab Med. 2019 Oct 25;57(11):1770-1776. doi: 10.1515/cclm-2019-0218.
9
Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway.硫酸吲哚酚通过可靶向热休克蛋白 90 依赖性途径诱导肾成纤维细胞活化。
Oxid Med Cell Longev. 2019 Apr 17;2019:2050183. doi: 10.1155/2019/2050183. eCollection 2019.
10
Indoxyl Sulfate-Induced Extracellular Vesicles Released from Endothelial Cells Stimulate Vascular Smooth Muscle Cell Proliferation by Inducing Transforming Growth Factor-Beta Production.硫酸吲哚酚诱导内皮细胞释放的细胞外囊泡通过诱导转化生长因子-β生成刺激血管平滑肌细胞增殖。
J Vasc Res. 2019;56(3):129-138. doi: 10.1159/000496796. Epub 2019 May 14.